03 Aug Brenda Hemmelgarn
Bio
Dr. Brenda Hemmelgarn joined the University of Alberta as Dean of the Faculty of Medicine & Dentistry on Jan. 1, 2020. Previously, at the University of Calgary’s Cumming School of Medicine, she was a professor in the Department of Medicine and Head of the Department of Community Health Sciences
She earned a Bachelor of Science degree in nursing and a master of nursing degree from the University of Saskatchewan, before going on to earn a PhD in epidemiology and biostatistics from McGill University and then an MD from McMaster University. Dr. Hemmelgarn went on to obtain subspecialty training in nephrology from the University of Calgary and continues to practice clinically to maintain front-line experience in health care and an in-depth perspective on healthcare issues.
For more than 35 years, Dr. Hemmelgarn has served in a variety of roles across health care, academics, and administration, including in her current role as vice-chair of the Alberta Health Services board of directors. In addition, Dr. Hemmelgarn was the principal investigator for the Alberta site of the Canadian Network for Observational Drug Effect Studies (DSEN-CNODES) since its inception. She participated as a Site Investigator and co-author on several of the CNODES studies and is a member of the DataBase and Knowledge Translation Teams.
Her research expertise focuses on using administrative data to improve care and outcomes for patients with kidney disease and other chronic conditions. She is also a strong advocate for patient-oriented research, patient engagement, and integrated knowledge translation. She has an international reputation for her research excellence, with more than $20 million in funding as principal investigator and more than 500 peer-reviewed publications. She holds the Roy and Vi Baay Chair in Kidney Research and is co-lead for the Interdisciplinary Chronic Disease Collaboration.
Among her many awards and honors, Dr. Hemmelgarn recently received the Alberta Science and Technology Leadership (ASTech) Foundation Award for Outstanding Achievement in Health Innovation and is a fellow of the Canadian Academy of Health Sciences.
CNODES Projects
Serotonin-norepinephrine reuptake inhibitors and the risk of AKI: A cohort study of eight administrative databases and meta-analysis
Content Expert, AlbertaProton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
, AlbertaUse of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Site Investigator, AlbertaAtypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Collaborator, AlbertaComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Project LeadData variability across Canadian administrative health databases: Differences in content, coding, and completeness
Collaborator, AlbertaThe use of atypical antipsychotics and the risk of breast cancer
Site Investigator, AlbertaThe use of atypical antipsychotics and the risk of breast cancer
Site Investigator, AlbertaUse of proton pump inhibitors and development of acute myocardial infarction
Site Investigator, AlbertaProton pump inhibitors and the risk of Clostridium difficile infection
Site Investigator, Alberta